#BEGIN_DRUGCARD DB07429

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C18H19BrN2O5S

# Chemical_IUPAC_Name:
2-{[4-bromo-3-(diethylsulfamoyl)benzene]amido}benzoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2010-09-15 15:21:34 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
2-({[4-bromo-3-(diethylsulfamoyl)phenyl]carbonyl}amino)benzoic acid

# HET_ID:
B82

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C18H19BrN2O5S/c1-3-21(4-2)27(25,26)16-11-12(9-10-14(16)19)17(22)20-15-8-6-5-7-13(15)18(23)24/h5-11H,3-4H2,1-2H3,(H,20,22)(H,23,24)

# InChI_Key:
InChIKey=VNOMZKMKBNFCMC-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
7435

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
455.323

# Molecular_Weight_Mono:
454.019805065

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
2.69

# Predicted_LogS:
-4.8

# Predicted_Water_Solubility:
6.64e-03 g/l

# Primary_Accession_No:
DB07429

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
1121782

# PubChem_Substance_ID:
99443900

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
Not Available

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CCN(CC)S(=O)(=O)C1=CC(=CC=C1Br)C(=O)NC1=CC=CC=C1C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:25:37 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm (Probable)

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_1_Essentiality:
Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AE016830

# Drug_Target_1_GenBank_ID_Protein:
29342120

# Drug_Target_1_GeneCard_ID:
fabH

# Drug_Target_1_Gene_Name:
fabH

# Drug_Target_1_Gene_Sequence:
>1344 bp
ATGCCCGACGTGGAAAGTTTTTGGCATAGCCTTGAAGAAGCCTATCAAGCGATTTTGTCG
GCGCCAAGTTTTGATGCTTGGATTAAAACCACACGCCCTTTGAAATTAGACAACAATCAA
TTGTGGCTAGAAGTCCCTTCTGCAGTTCATCGTGATTACTGGGAAAAAAATCTTTCGGCA
AAAATTGTCGAAACTGGATTTAAATTGACCGGTGCAGAAGTGATGCCCCATTTTGTTGTT
GCCGATGAAAAAGACGCAGCACTGGCACAAGAACTCGAAGAACCTGCCGAAGAAGAAGTT
GTTTTTAGTGAACAAAGTAAAAAAGCGATGCTTAATCCTAAGTACACTTTCGACACCTTC
GTTATTGGTAAAGGAAACCAAATGGCTCATGCTGCAGCGCTTGTTGTTGCCGAGGATCCA
GGTTCGATTTACAATCCCCTTTTCTTCTATGGTGGTGTAGGGTTAGGGAAAACCCATTTG
ATGCATGCTATTGGTCATCAAATGTTAGTGAATCAACCAGATGCCAAAGTCAAATATGTT
AGTAGCGAAACGTTTACGAATGAATTTATCAACTCAATTCAAACAAAGACATCCGAACAA
TTTCGGAAAGAATATCGCAATGTTGACTTATTATTAGTCGATGATATTCAATTTTTGGCG
GAAAAAGAAGCAACATTGGAAGAATTTTTCCATACCTTCAACGATCTTTACAATGAAAAT
AAACAAATTGTTTTAACAAGTGATCGCCCGCCGAATGATATTCCAAAATTACCTGAACGA
TTAGTTTCTCGCTTTGCTTGGGGTTTGTCTGTCGATATCACCCCGCCTGATTTAGAAACA
CGGATTGCAATTTTGCGCAAAAAAGCAGATGCCGAGCGTTTAGAAATTCCGGATGATACA
CTAAGTTATATCGCTGGTCAAATTGATTCCAACATCCGTGAATTAGAGGGTGCTTTGGTC
CGTGTTCAAGCCTTTGCAACTATTAATGGAGAAGATATTACCACTAGTTTAGCGGCGGAC
GCCTTGAAATCTCTAAAATCAGTTGGTAGTAAAAATCAATTGTCCATTTTACAAATTCAA
GAAGAAGTATCCAAATATTATCATGTGCCTCTTAAAGATTTAAAAGGGAAAAAACGGGTG
AAAACAATTGTGGTTCCTCGTCAAATCTCAATGTATCTTGCTAGAGAAATGACCGACAAT
TCCTTGCCAAAAATTGGTGCCGAATTTGGCGGCAAAGATCATACAACGGTGATTCATGCG
CACGAAAAGATTCAGCAATTATTGGAAAAAGATCCAGCGATTCAAAAAGAAGTCAGTGAA
ATTAAAAATTTATTGAACTCTTAG

# Drug_Target_1_General_Function:
Lipid transport and metabolism

# Drug_Target_1_General_References:
12663927	Paulsen IT, Banerjei L, Myers GS, Nelson KE, Seshadri R, Read TD, Fouts DE, Eisen JA, Gill SR, Heidelberg JF, Tettelin H, Dodson RJ, Umayam L, Brinkac L, Beanan M, Daugherty S, DeBoy RT, Durkin S, Kolonay J, Madupu R, Nelson W, Vamathevan J, Tran B, Upton J, Hansen T, Shetty J, Khouri H, Utterback T, Radune D, Ketchum KA, Dougherty BA, Fraser CM: Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus faecalis. Science. 2003 Mar 28;299(5615):2071-4.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
6370

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
35181.6

# Drug_Target_1_Name:
3-oxoacyl-[acyl-carrier-protein] synthase 3

# Drug_Target_1_Number_of_Residues:
321

# Drug_Target_1_PDB_ID:
Not Available

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF08541	ACP_syn_III_C
PF08545	ACP_syn_III

# Drug_Target_1_Protein_Sequence:
>3-oxoacyl-[acyl-carrier-protein] synthase 3
MKNYARISCTSRYVPENCVTNHQLSEMMDTSDEWIHSRTGISERRIVTQENTSDLCHQVA
KQLLEKSGKQASEIDFILVATVTPDFNMPSVACQVQGAIGATEAFAFDISAACSGFVYAL
SMAEKLVLSGRYQTGLVIGGETFSKMLDWTDRSTAVLFGDGAAGVLIEAAETPHFLNEKL
QADGQRWAALTSGYTINESPFYQGHKQASKTLQMEGRSIFDFAIKDVSQNILSLVTDETV
DYLLLHQANVRIIDKIARKTKISREKFLTNMDKYGNTSAASIPILLDEAVENGTLILGSQ
QRVVLTGFGGGLTWGSLLLTL

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Catalyzes the condensation reaction of fatty acid synthesis by the addition to an acyl acceptor of two carbons from malonyl-ACP. Catalyzes the first condensation reaction which initiates fatty acid synthesis and may therefore play a role in governing the total rate of fatty acid production. Possesses both acetoacetyl-ACP synthase and acetyl transacylase activities. Its substrate specificity determines the biosynthesis of branched- chain and/or straight-chain of fatty acids (By similarity)

# Drug_Target_1_SwissProt_ID:
Q820T1

# Drug_Target_1_SwissProt_Name:
FABH_ENTFA

# Drug_Target_1_Synonyms:
3-oxoacyl-[acyl-carrier-protein] synthase III
Beta-ketoacyl-ACP synthase III
KAS III

# Drug_Target_1_Theoretical_pI:
5.19

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB07429
